A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.
Mar 9 2024University of Michigan
With most viruses, when people get infected, they get sick for a while and then the immune system kicks in and the virus is cleared. But with HIV, once a patient is infected, that virus will persist for their entire life-;meaning they must remain on treatments indefinitely." One key to HIV's ability to remain hidden in patients' cells is a protein that the virus makes, called Nef.
Another major challenge with developing CMA as an anti-HIV drug is that Nef is not CMA's primary target. Collins' lab team ran the new compounds through a battery of tests to measure their toxicity to cells, as well as how they affected the activities of both HIV Nef and V-ATPase.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Researchers open new leads in anti-HIV drug development, using a compound found in natureA team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity.
続きを読む »
Lit from within: How tiny wireless bulbs could revolutionize clinical health careResearchers from the University of St Andrews and the University of Cologne have developed a new device platform that allows for smaller wireless light sources to be placed within the human body.
続きを読む »
Brain of Lewiston gunman showed signs of traumatic injury, researchers sayThe brain of a gunman who killed 18 people and injured 13 others in Lewiston, Maine, showed signs of significant traumatic injury at the time of the mass…
続きを読む »
Researchers uncover new clues about links between parent age and congenital disordersA new paper in Genome Biology and Evolution finds that the link between paternal age and rare congenital disorders is more complex than scientists had previously thought.
続きを読む »
Researchers create more realistic synthetic human mini heartsThanks to advancements in the development of patented synthetic human-like hearts first created at Michigan State, researchers can study human heart development and congenital heart disease on highly accurate models.
続きを読む »
Researchers develop promising recombinant flu vaccine using nanoliposome technologyRecombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.
続きを読む »